Security
Nautilus Biotechnology, Inc. Common Stock · NAUT
NAUTNASDAQCommon stockCurrentCIK 1808805Updated Nov 15, 2026
Name history
ARYA Sciences Acquisition Corp III · through Jun 8, 2021
NAUT price & chart
Loading TradingView…
NASDAQ:NAUT on TradingView ↗In the news
Recent filings
SCHEDULE 13D/A - filed by PERCEPTIVE ADVISORS LLC regarding Nautilus Biotechnology, Inc.
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
EFFECT filing
424B5 filing
Show 5 more recent filings
SCHEDULE 13D/A - filed by AH Bio Fund II, L.P. regarding Nautilus Biotechnology, Inc.
Entry into a Material Definitive Agreement · Termination of a Material Definitive Agreement
Items 1.01, 1.02, 9.01
S-3 filing
SCHEDULE 13D/A - filed by AH Bio Fund II, L.P. regarding Nautilus Biotechnology, Inc.
SCHEDULE 13D/A - filed by PERCEPTIVE ADVISORS LLC regarding Nautilus Biotechnology, Inc.
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 200,915,000Source | 259,704,000Source | 163,576,000Source | 213,189,000Source | 272,747,000Source | 177,779,000Source | 227,690,000Source | 288,650,000Source | 191,112,000Source | 242,743,000Source | 305,565,000Source | 350,052,000Source |
| Property, Plant and Equipment, NetUSD | 3,624,000Source | 4,324,000Source | 3,999,000Source | 3,728,000Source | 4,694,000Source | 3,635,000Source | 3,790,000Source | 4,525,000Source | 3,457,000Source | 4,076,000Source | 4,267,000Source | 3,700,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 23,875,000Source | 4,409,000Source | 13,166,000Source | 34,457,000Source | 24,885,000Source | 14,626,000Source | 33,238,000Source | 25,729,000Source | 12,388,000Source | 27,646,000Source | 19,397,000Source | 114,523,000Source |
| Assets, CurrentUSD | 134,325,000Source | 144,205,000Source | 87,626,000Source | 150,725,000Source | 170,933,000Source | 98,832,000Source | 141,601,000Source | 185,094,000Source | 105,963,000Source | 132,826,000Source | 176,837,000Source | 187,209,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,898,000Source | 3,596,000Source | 3,595,000Source | 2,852,000Source | 3,490,000Source | 2,963,000Source | 2,791,000Source | 3,728,000Source | 2,557,000Source | 2,933,000Source | 3,419,000Source | 2,738,000Source |
| Operating Lease, Right-of-Use AssetUSD | 24,727,000Source | 29,377,000Source | 25,619,000Source | 25,920,000Source | 30,474,000Source | 26,631,000Source | 27,096,000Source | 31,559,000Source | 27,773,000Source | 28,256,000Source | 32,634,000Source | 28,866,000Source |
| Other Assets, NoncurrentUSD | 1,180,000Source | 1,180,000Source | 1,177,000Source | 1,180,000Source | 1,180,000Source | 1,176,000Source | 1,180,000Source | 1,180,000Source | 1,180,000Source | 1,180,000Source | 1,180,000Source | 1,108,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 31,776,000Source | 36,270,000Source | 32,464,000Source | 32,095,000Source | 37,468,000Source | 33,364,000Source | 33,255,000Source | 39,158,000Source | 34,139,000Source | 34,013,000Source | 40,212,000Source | 35,128,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 13,000Source | 12,000Source |
| Additional Paid in CapitalUSD | 487,165,000Source | 478,115,000Source | 492,616,000Source | 485,669,000Source | 474,791,000Source | 491,210,000Source | 483,865,000Source | 471,193,000Source | 488,737,000Source | 481,679,000Source | 467,834,000Source | 455,330,000Source |
| Retained Earnings (Accumulated Deficit)USD | -318,239,000Source | -255,425,000Source | -361,186,000Source | -304,665,000Source | -238,979,000Source | -346,717,000Source | -289,632,000Source | -220,969,000Source | -332,020,000Source | -273,019,000Source | -202,239,000Source | -138,564,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 200,000Source | 731,000Source | -331,000Source | 77,000Source | -546,000Source | -91,000Source | 189,000Source | -745,000Source | 243,000Source | 57,000Source | -255,000Source | -1,854,000Source |
| Stockholders' Equity Attributable to ParentUSD | 169,139,000Source | 223,434,000Source | 131,112,000Source | 181,094,000Source | 235,279,000Source | 144,415,000Source | 194,435,000Source | 249,492,000Source | 156,973,000Source | 208,730,000Source | 265,353,000Source | 314,924,000Source |
| Liabilities and EquityUSD | 200,915,000Source | 259,704,000Source | 163,576,000Source | 213,189,000Source | 272,747,000Source | 177,779,000Source | 227,690,000Source | 288,650,000Source | 191,112,000Source | 242,743,000Source | 305,565,000Source | 350,052,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 8,982,000Source | 8,662,000Source | 8,639,000Source | 8,137,000Source | 8,681,000Source | 8,343,000Source | 8,156,000Source | 9,212,000Source | 7,952,000Source | 7,632,000Source | 9,122,000Source | 6,791,000Source |
| Operating Lease, Liability, CurrentUSD | 4,209,000Source | 3,959,000Source | 3,991,000Source | 4,225,000Source | 3,815,000Source | 3,852,000Source | 4,242,000Source | 3,675,000Source | 3,832,000Source | 4,097,000Source | 3,538,000Source | 1,991,000Source |
| Accounts Payable, CurrentUSD | 893,000Source | 1,487,000Source | 1,095,000Source | 974,000Source | 1,627,000Source | 1,186,000Source | 841,000Source | 1,860,000Source | 943,000Source | 987,000Source | 1,639,000Source | 1,272,000Source |
| Operating Lease, Liability, NoncurrentUSD | 22,794,000Source | 27,608,000Source | 23,825,000Source | 23,958,000Source | 28,787,000Source | 25,021,000Source | 25,099,000Source | 29,946,000Source | 26,187,000Source | 26,381,000Source | 31,090,000Source | 28,337,000Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 131,400,000Source | 140,600,000Source | 84,000,000Source | 147,900,000Source | 167,400,000Source | 95,900,000Source | 138,800,000Source | 181,400,000Source | 103,400,000Source | 129,900,000Source | 173,400,000Source | 184,500,000Source |
| Inventory, Net | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 1,362,000Source | 2,168,000Source | 6,844,000Source | 12,701,000Source | 12,137,000Source | 10,380,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 200,000Source | -131,000Source | -69,000Source | -578,000Source | 393,000Source | -561,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -13,100,000Source | -13,937,000Source | -50,696,000Source | -59,145,000Source | -51,711,000Source | -45,806,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | 14,233,000Source | 19,511,000Source | 35,224,000Source | 66,250,000Source | -43,735,000Source | -25,740,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 510,000Source | 219,000Source | 1,277,000Source | 2,122,000Source | 2,442,000Source | 2,324,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 1,105,000Source | 18,000Source | 214,000Source | 1,144,000Source | 368,000Source | 562,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 2,238,000Source | 5,592,000Source | -15,258,000Source | 8,249,000Source | -95,078,000Source | -70,984,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 24,877,000Source | 5,411,000Source | 14,168,000Source | 35,459,000Source | 15,628,000Source | 34,240,000Source | 13,390,000Source | 28,648,000Source | 20,399,000Source | 115,477,000Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 131,400,000Source | 140,600,000Source | 84,000,000Source | 147,900,000Source | 95,900,000Source | 138,800,000Source | 103,400,000Source | 129,900,000Source | 173,400,000Source | 184,500,000Source |
| DepreciationUSD | — | — | 400,000Source | 500,000Source | 300,000Source | 400,000Source | 334,000Source | 465,000Source | 1,700,000Source | 1,975,000Source | 1,849,000Source | 1,217,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | -84,000Source | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 5,867,000Source | 6,812,000Source | — | 6,703,000Source | — | 7,308,000Source | 25,727,000Source | 30,999,000Source | 28,901,000Source | 25,946,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -13,574,000Source | -16,446,000Source | -14,469,000Source | -15,033,000Source | -14,697,000Source | -16,613,000Source | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -13,574,000Source | -16,446,000Source | -14,469,000Source | -15,033,000Source | -14,697,000Source | -16,613,000Source | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Nonoperating Income (Expense)USD | — | — | 1,898,000Source | 2,654,000Source | 1,294,000Source | 2,064,000Source | 1,427,000Source | 2,231,000Source | 7,836,000Source | 10,696,000Source | 12,477,000Source | 5,694,000Source |
| Operating ExpensesUSD | — | — | 15,472,000Source | 19,100,000Source | 15,938,000Source | 17,097,000Source | 16,124,000Source | 18,844,000Source | 66,837,000Source | 81,476,000Source | 76,152,000Source | 63,618,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 1,105,000Source | 18,000Source | 58,000Source | 620,000Source | 104,000Source | 330,000Source |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -13,574,000Source | -16,446,000Source | -14,469,000Source | -15,033,000Source | -14,697,000Source | -16,613,000Source | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.11Source | -0.13Source | -0.11Source | -0.12Source | -0.12Source | -0.13Source | -0.47Source | -0.56Source | -0.51Source | -0.46Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.11Source | -0.13Source | -0.11Source | -0.12Source | -0.12Source | -0.13Source | -0.47Source | -0.56Source | -0.51Source | -0.46Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 126,305,122Source | 125,452,572Source | 127,135,738Source | 126,204,632Source | 126,634,782Source | 126,144,240Source | 126,256,583Source | 125,426,509Source | 124,919,144Source | 124,589,555Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 126,305,122Source | 125,452,572Source | 127,135,738Source | 126,204,632Source | 126,634,782Source | 126,144,240Source | 126,256,583Source | 125,426,509Source | 124,919,144Source | 124,589,555Source |
| Additional Financial Items | ||||||||||||
| General and Administrative ExpenseUSD | — | — | 5,867,000Source | 6,812,000Source | — | 6,703,000Source | — | 7,308,000Source | 25,727,000Source | 30,999,000Source | 28,901,000Source | 25,946,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | 1,903,000Source | 2,674,000Source | 1,307,000Source | 2,080,000Source | 1,442,000Source | 2,231,000Source | 7,868,000Source | 10,780,000Source | 12,550,000Source | 5,816,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -13,574,000Source | -16,446,000Source | -14,469,000Source | -15,033,000Source | -14,697,000Source | -16,613,000Source | -59,001,000Source | -70,780,000Source | -63,675,000Source | -57,924,000Source |
| Nonoperating Income (Expense)USD | — | — | 1,898,000Source | 2,654,000Source | 1,294,000Source | 2,064,000Source | 1,427,000Source | 2,231,000Source | 7,836,000Source | 10,696,000Source | 12,477,000Source | 5,694,000Source |
| Operating ExpensesUSD | — | — | 15,472,000Source | 19,100,000Source | 15,938,000Source | 17,097,000Source | 16,124,000Source | 18,844,000Source | 66,837,000Source | 81,476,000Source | 76,152,000Source | 63,618,000Source |
| Research and Development ExpenseUSD | — | — | 9,605,000Source | 12,288,000Source | 9,613,000Source | 10,394,000Source | 9,707,000Source | 11,536,000Source | 41,110,000Source | 50,477,000Source | 47,251,000Source | 37,672,000Source |
| Total Revenue | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Cost of Goods and Services Sold | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
| Selling, General and Administrative Expense | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Other Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Offerings
Registration 333-298884
Filing attachments
acrv-ex99_1.htm · SCHEDULE 13D/A · 2026-11-03
Schedule A Fund Date Transaction Number of Shares Price1 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Perceptive Life Sciences Master Fund, Ltd. 7/28/2026 Sell Short 1,933 $1.3081 Perceptive Life Sciences Master Fund, Ltd. 9/29/2026 Sale 14,737 $1.5000 Perceptive Life Sciences Master…
Read attachment ↗